Wenyuan Group Corp. (WYGC) reported no revenue in either the three- or six-month periods ended June 30, 2026. Net loss was $52,416 for the three months and $116,090 for the six months, compared with $78,819 and $164,779 in the corresponding 2025 periods. Operating expenses were $51,819 and $115,235, respectively, versus $78,392 and $162,380.
At June 30, 2026, cash was $841 and the working capital deficit was $156,548; operating activities used $35,901 during the six-month period. The company said these conditions raise substantial doubt about its ability to continue as a going concern. Management plans to pursue profitable operations and seek additional working capital from its majority shareholder and president, but said there is no assurance its plans will be sufficient. The company also concluded its disclosure controls were not effective in timely alerting officers to material information.
Wenyuan Group Corp. reported another loss-making quarter for the three months ended March 31, 2026, with no revenue and a net loss of $63,674, narrower than the $85,960 loss a year earlier. Operating expenses fell to $63,416 from $83,988, mainly from lower selling, general and administrative costs.
Total assets declined to $55,937, while total liabilities rose to $132,003, leaving stockholders’ deficit at $76,066. Cash was only $151 and the working capital deficit widened to $104,718, reflecting reliance on related-party funding, including $10,977 of shareholder loans.
Management states that recurring losses, an accumulated deficit of $21,928,508, minimal cash, and adverse financial ratios raise substantial doubt about the company’s ability to continue as a going concern. Internal disclosure controls and procedures were also deemed not effective, although no material changes in internal control over financial reporting were identified during the quarter.
Wenyuan Group Corp., a Nevada holding company operating in China, files its annual report describing a small cultural and health products business. Through subsidiary HWAC, it generated $24,627 of sales in 2025, compared with $60,285 in 2024.
The company discontinued its aquaculture products segment in March 2024 and now focuses on cultural and health product sales via its WeChat-based Huanyumeiyuan Mall. As of June 30, 2025, non‑affiliate equity was valued at $1,933,487, and 82,610,375 common shares were outstanding as of May 7, 2026.
Wenyuan Group Corp. notified the SEC that it cannot timely file its Form 10-K for the year ending December 31, 2025 because it was unable to obtain necessary financial information. The company states it anticipates submitting the filing within the extension period provided by Rule 12b-25.
Wenyuan Group Corp. (WYGC) filed its quarterly report for the period ended September 30, 2025. The company reported no revenue for both the three- and nine-month periods, compared with $67,968 in offline product sales in the first nine months of 2024, reflecting a halt in its cultural and health product business.
Net loss narrowed to $239,602 for the nine months ended September 30, 2025 from $882,004 a year earlier, mainly because 2024 included $570,000 of share-based compensation. Cash fell to $7,608 with a working capital deficit of $305,645 and an accumulated deficit of $21,465,393, leading management to state there is substantial doubt about the company’s ability to continue as a going concern. The company also recorded a litigation reserve of approximately $266,869 related to a Chinese court ruling over an office suite purchase.